| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Hydroxycarbamide |
| Brand | Siklos® |
| Indication | For use in the prevention of painful, recurrent vaso-occlusive crises, including acute chest syndrome, in adults, adolescents and children over 2 years of age suffering from symptomatic sickle-cell disease. |
| Assessment Process | |
| Rapid review commissioned | 22/08/2011 |
| Rapid review completed | 06/09/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended. |